Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs
The Department of Labor finalized a rule that seeks to bring more transparency into PBM compensation.
California Signs PBM Law: As Federal PBM Regulation Lags, the States Step Up
With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Will the Arkansas PBM Law Survive A Judge’s Rejection?
A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state. Although the state plans to appeal, one expert says the law likely has no future.
Why CVS, Express Scripts Are Suing Over the Arkansas PBM Law
Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express Scripts are suing, claiming the law is unconstitutional.
The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful?
The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in "anticompetitive and unfair rebating practices” as it relates to insulin. One legal expert believes the FTC might win this legal battle.
NCPA, Providers File Lawsuit Against UHG Over Change Healthcare Cyberattack
The National Community Pharmacists Association and providers argued that Change Healthcare didn't take the needed precautions against the cyberattack that happened earlier this year.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
The FTC Released a Scathing Interim Report on PBMs. What’s Next?
The Federal Trade Commission recently released an interim report that details how the practices of pharmacy benefit managers negatively impact patients and pharmacies. Some experts hope for legislative action based on the report.